Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GAPDH | P04406 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18271832 | 1.00 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL17685117 | 1.00 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL16556366 | 1.00 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL929589 | 1.00 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL24371811 | 0.88 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL19326428 | 0.88 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL929484 | 0.88 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL17560666 | 0.88 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL21015462 | 0.88 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL19326334 | 0.88 | ALDH1A1 (0.50) | ALDH1A1POLBGAAMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2855497-B1 | PROCESS FOR THE PREPARATION OF 2-DEOXY-2-FLUORO-2-METHYL-D-RIBOFURANOSYL NUCLEOSIDE COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2016-04-20 | — | — | EP | disclosed |
| US-8912321-B2 | Preparation of nucleosides ribofuranosyl pyrimidines | GILEAD PHARMASSET LLC (US) | 2014-12-16 | — | — | US | disclosed |
| US-8912321-B2 | Preparation of nucleosides ribofuranosyl pyrimidines | GILEAD PHARMASSET LLC (US) | 2014-12-16 | — | — | US | disclosed |
| US-20100056770-A1 | PREPARATION OF NUCLEOSIDES RIBOFURANOSYL PYRIMIDINES | GILEAD PHARMASSET LLC | 2010-03-04 | — | — | US | disclosed |
| US-20080139802-A1 | Converting 2'-deoxy-2'-fluoro-2'-methyl-D-ribonolactones derivatives to 3-fluoro-3-methyl-2-chlorofuran compounds using chlorinating agent such as sulfuryl chloride, thionyl chloride or phosphorus oxychloride and tetrabutylammonium bromide | PHARMASSET, INC. | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139802-A1 | Converting 2'-deoxy-2'-fluoro-2'-methyl-D-ribonolactones derivatives to 3-fluoro-3-methyl-2-chlorofuran compounds using chlorinating agent such as sulfuryl chloride, thionyl chloride or phosphorus oxychloride and tetrabutylammonium bromide | FBL, NSUN2, RNGTT | ALDH1A1 3181/4885POLB 43/4885GAA 4248/4885 |
| US-20100056770-A1 | PREPARATION OF NUCLEOSIDES RIBOFURANOSYL PYRIMIDINES | RNGTT, UMPS, NT5C3B | ALDH1A1 1279/4885POLB 133/4885GAA 1580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.